Related references
Note: Only part of the references are listed.DILI-Stk: An Ensemble Model for the Prediction of Drug-induced Liver Injury of Drug Candidates
Jingyu Lee et al.
CURRENT BIOINFORMATICS (2022)
PredMS: a random forest model for predicting metabolic stability of drug candidates in human liver microsomes
Jae Yong Ryu et al.
BIOINFORMATICS (2022)
Development of a FOXM1-DBD Binding Assay for High-Throughput Screening Using TR-FRET Assay
Mi Young Lee et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2021)
FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase
Nathakan Klinhom-On et al.
LIFE SCIENCES (2021)
The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer
Karan Ulhaka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells
Mikhail S. Chesnokov et al.
CELL DEATH & DISEASE (2021)
LightBBB: computational prediction model of blood-brain-barrier penetration based on LightGBM
Bilal Shaker et al.
BIOINFORMATICS (2021)
DeepHIT: a deep learning framework for prediction of hERG-induced cardiotoxicity
Jae Yong Ryu et al.
BIOINFORMATICS (2020)
2-D chemical structure image-based in silico model to predict agonist activity for androgen receptor
Myeong-Sang Yu et al.
BMC BIOINFORMATICS (2020)
Computational determination of hERG-related cardiotoxicity of drug candidates
Hyang-Mi Lee et al.
BMC BIOINFORMATICS (2019)
Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells
Mesayamas Kongsema et al.
ONCOLOGY REPORTS (2019)
A structure-activity relationship study of Forkhead Domain Inhibitors (FDI): The importance of halogen binding interactions
Seyed Amirhossein Tabatabaei Dakhili et al.
BIOORGANIC CHEMISTRY (2019)
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
Daehwan Kim et al.
NATURE BIOTECHNOLOGY (2019)
High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer
Mee Young Kim et al.
JOURNAL OF CANCER (2019)
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
Yvonne Ziegler et al.
NPJ BREAST CANCER (2019)
FoxM1 is a promising candidate target in the treatment of breast cancer
Xiao-Feng Lu et al.
ONCOTARGET (2018)
FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop
Huiling Yang et al.
ANTI-CANCER DRUGS (2018)
Untying the knot of transcription factor druggability: Molecular modeling study of FOXM1 inhibitors
S. Amirhossein Tabatabaei-Dakhili et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2018)
Phyto-polyphenols as potential inhibitors of breast cancer metastasis
Dimiter Avtanski et al.
MOLECULAR MEDICINE (2018)
Honokiol is a FOXM1 antagonist
Marianna Halasi et al.
CELL DEATH & DISEASE (2018)
Cancer cell line specific co-factors modulate the FOXM1 cistrome
Yue Wang et al.
ONCOTARGET (2017)
Selective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling
Fanny Langlet et al.
CELL (2017)
In silico investigation of FOXM1 binding and novel inhibitors in epithelial ovarian cancer
Yi Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
StringTie enables improved reconstruction of a transcriptome from RNA-seq reads
Mihaela Pertea et al.
NATURE BIOTECHNOLOGY (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Synthesis and anticancer activity of quinopimaric and maleopimaric acids' derivatives
Elena V. Tretyakova et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Downregulation of FoxM1 inhibits proliferation, invasion and angiogenesis of He La cells in vitro and in vivo
Hong Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition
Michael V. Gormally et al.
NATURE COMMUNICATIONS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Synthesis and antitumor activity evaluation of maleopimaric acid N-aryl imide atropisomers
Gui-yang Yao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer
C. Yang et al.
CANCER GENE THERAPY (2013)
Forkhead box proteins: tuning forks for transcriptional harmony
Eric W. -F. Lam et al.
NATURE REVIEWS CANCER (2013)
Thiostrepton, proteasome inhibitors and FOXM1
Andrei L. Gartel
CELL CYCLE (2011)
The transcription factor FOXM1 is a cellular target of the natural product thiostrepton
Nagaratna S. Hegde et al.
NATURE CHEMISTRY (2011)
REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms
Fran Supek et al.
PLOS ONE (2011)
CHARMM General Force Field: A Force Field for Drug-Like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields
K. Vanommeslaeghe et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence
D. R. Littler et al.
NUCLEIC ACIDS RESEARCH (2010)
A novel mode of FoxM1 regulation Positive auto-regulatory loop
Marianna Halasi et al.
CELL CYCLE (2009)
CHARMM: The Biomolecular Simulation Program
B. R. Brooks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Deletion of Forkhead Box M1 Transcription Factor from Respiratory Epithelial Cells Inhibits Pulmonary Tumorigenesis
I-Ching Wang et al.
PLOS ONE (2009)
Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
Jimmy M-M. Kwok et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
The central domain of transcription factor FOXM1c directly interacts with itself in vivo and switches from an essential to an inhibitory domain depending on the FOXM1c binding site
Inken Wierstra et al.
BIOLOGICAL CHEMISTRY (2007)
FoxM1: At the crossroads of ageing and cancer
Jamila Laoukili et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1
Senthil K. Radhakrishnan et al.
CANCER RESEARCH (2006)
Forkhead box m1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase
IC Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe
DR Wonsey et al.
CANCER RESEARCH (2005)
FoxM1 is required for execution of the mitotic programme and chromosome stability
J Laoukili et al.
NATURE CELL BIOLOGY (2005)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Share Paper
